Vladimir Pech
Hospitalist · Aurora, CONPI 1639509490
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 22 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 20.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $144, 2.6 times the $55 reported in 2020. Among hospitalist clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 22 payments — averaging $19.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$90
- Merck$82
- Pfizer$70
- GSK$50
- Novo Nordisk$40
- AbbVie$27
- plus $75 from 5 others
What the payments were for
- Food & beverage$433100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 1 | $90 |
| Merck | 6 | $82 |
| Pfizer | 4 | $70 |
| GSK | 3 | $50 |
| Novo Nordisk | 2 | $40 |
| AbbVie | 1 | $27 |
| Dermira, Inc. | 1 | $16 |
| Amgen | 1 | $16 |
| VBI Vaccine (delaware) Inc. | 1 | $15 |
| Cranial Technologies, Inc | 1 | $14 |
| Lilly USA, LLC | 1 | $13 |
How this compares
$433 in reported general payments places this provider in the 90th percentile of 547 hospitalist providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 42 | $485 |
| Atorvastatin Calcium | 44 | $375 |
| Omeprazole | 16 | $348 |
| Losartan Potassium | 25 | $313 |
| Levothyroxine Sodium | 36 | $192 |
| Amlodipine Besylate | 24 | $177 |
| Tamsulosin Hcl | 15 | $168 |
| Metformin Hcl | 13 | $96 |
| Hydrochlorothiazide | 15 | $94 |
| Trazodone Hcl | 18 | $91 |
| Lisinopril | 23 | $89 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Aurora
- Tejas PatilAurora$94K
- Michael SolaAurora$11K
- Susan CalcaterraAurora$6K
- Jeannette GuerrasioAurora$5K
- Mark BrittanAurora$4K
- Lilia CervantesAurora$3K
- Erin GordonAurora$3K
- Hemali PatelAurora$2K
- Alexander SunAurora$1K
- Benjamin WalkerAurora$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.